Russell Investments Group, Ltd. Dexcom Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Dexcom Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 118,244 shares of DXCM stock, worth $8.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

118,244

Previous 126,919 6.84%

Holding current value

$8.83 Million

Previous $14.4 Million 44.93%

% of portfolio

0.01%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $555,200 - $1.01 Million	-8,675 Reduced 6.84%	118,244 $7.92 Million
Q2 2024 Aug 08, 2024	BUY	$110.31 - $140.45 $3.01 Million - $3.83 Million	27,298 Added 27.4%	126,919 $14.4 Million
Q1 2024 May 08, 2024	SELL	$114.22 - $140.1 $4.73 Million - $5.8 Million	-41,384 Reduced 29.35%	99,621 $13.8 Million
Q4 2023 Feb 05, 2024	SELL	$75.49 - $124.16 $577,649 - $950,072	-7,652 Reduced 5.15%	141,005 $17.5 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $2.34 Million - $3.75 Million	27,168 Added 22.36%	148,657 $13.9 Million
Q2 2023 Aug 10, 2023	SELL	$112.47 - $130.98 $4.88 Million - $5.68 Million	-43,368 Reduced 26.31%	121,489 $15.6 Million
Q1 2023 May 09, 2023	BUY	$104.0 - $122.92 $4.16 Million - $4.91 Million	39,982 Added 32.02%	164,857 $19.2 Million
Q4 2022 Feb 08, 2023	BUY	$84.98 - $122.67 $3.34 Million - $4.82 Million	39,295 Added 45.92%	124,875 $14.1 Million
Q3 2022 Nov 04, 2022	SELL	$76.35 - $94.18 $1.27 Million - $1.56 Million	-16,608 Reduced 16.25%	85,580 $6.96 Million
Q2 2022 Jul 29, 2022	BUY	$67.99 - $132.89 $4.74 Million - $9.26 Million	69,655 Added 214.11%	102,188 $7.65 Million
Q1 2022 May 05, 2022	SELL	$94.08 - $130.2 $4.65 Million - $6.44 Million	-49,449 Reduced 60.32%	32,533 $16.7 Million
Q4 2021 Jan 21, 2022	SELL	$129.87 - $162.82 $2.95 Million - $3.7 Million	-22,704 Reduced 21.69%	81,982 $44.1 Million
Q3 2021 Nov 08, 2021	SELL	$106.71 - $143.18 $526,613 - $706,593	-4,935 Reduced 4.5%	104,686 $57.2 Million
Q2 2021 Aug 04, 2021	SELL	$80.99 - $107.93 $536,963 - $715,575	-6,630 Reduced 5.7%	109,621 $46.8 Million
Q1 2021 May 10, 2021	SELL	$84.79 - $104.74 $2.63 Million - $3.25 Million	-31,008 Reduced 21.06%	116,251 $41.7 Million
Q4 2020 Feb 08, 2021	BUY	$78.0 - $104.5 $1.99 Million - $2.67 Million	25,525 Added 20.97%	147,259 $54.2 Million
Q3 2020 Nov 09, 2020	SELL	$95.51 - $112.95 $1.17 Million - $1.38 Million	-12,258 Reduced 9.15%	121,734 $50.1 Million
Q2 2020 Aug 05, 2020	SELL	$62.68 - $105.34 $2.64 Million - $4.43 Million	-42,055 Reduced 23.89%	133,992 $54.2 Million
Q1 2020 May 06, 2020	BUY	$47.79 - $75.63 $7.21 Million - $11.4 Million	150,902 Added 600.13%	176,047 $47.6 Million
Q4 2019 Jan 29, 2020	BUY	$36.62 - $57.29 $101,071 - $158,120	2,760 Added 12.33%	25,145 $5.47 Million
Q3 2019 Nov 01, 2019	BUY	$35.53 - $43.8 $41,747 - $51,465	1,175 Added 5.54%	22,385 $3.34 Million
Q2 2019 Aug 09, 2019	SELL	$27.84 - $38.92 $80,040 - $111,895	-2,875 Reduced 11.94%	21,210 $3.16 Million
Q1 2019 May 13, 2019	SELL	$28.07 - $38.18 $507,758 - $690,638	-18,089 Reduced 42.89%	24,085 $2.87 Million
Q4 2018 Feb 11, 2019	SELL	$26.99 - $37.37 $334,649 - $463,350	-12,399 Reduced 22.72%	42,174 $5.02 Million
Q3 2018 Oct 26, 2018	BUY	$23.35 - $36.72 $304,484 - $478,828	13,040 Added 31.4%	54,573 $7.81 Million
Q2 2018 Aug 08, 2018	SELL	$17.54 - $25.22 $858,337 - $1.23 Million	-48,936 Reduced 54.09%	41,533 $3.94 Million
Q1 2018 May 11, 2018	SELL	$13.06 - $18.54 $3.33 Million - $4.72 Million	-254,627 Reduced 73.78%	90,469 $6.71 Million
Q4 2017 Feb 06, 2018	BUY	$11.12 - $15.38 $123,632 - $170,994	11,118 Added 3.33%	345,096 $19.8 Million
Q3 2017 Nov 07, 2017	BUY	$11.36 - $18.98 $3.79 Million - $6.34 Million	333,978	333,978 $16.3 Million

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

349M

Call Options Held

5.66M

Put Options Held

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Dexcom Inc Transaction History